2 false false false false false false false false false false true false false false false false false No description of principal activity 2023-07-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 13481836 2023-07-01 2024-06-30 13481836 2024-06-30 13481836 2023-06-30 13481836 2022-07-01 2023-06-30 13481836 2023-06-30 13481836 2022-06-30 13481836 bus:Director1 2023-07-01 2024-06-30 13481836 core:WithinOneYear 2024-06-30 13481836 core:WithinOneYear 2023-06-30 13481836 core:ShareCapital 2024-06-30 13481836 core:ShareCapital 2023-06-30 13481836 core:RetainedEarningsAccumulatedLosses 2024-06-30 13481836 core:RetainedEarningsAccumulatedLosses 2023-06-30 13481836 bus:Director1 2023-06-30 13481836 bus:Director1 2024-06-30 13481836 bus:Director1 2022-06-30 13481836 bus:Director1 2023-06-30 13481836 bus:Director1 2022-07-01 2023-06-30 13481836 bus:SmallEntities 2023-07-01 2024-06-30 13481836 bus:AuditExemptWithAccountantsReport 2023-07-01 2024-06-30 13481836 bus:SmallCompaniesRegimeForAccounts 2023-07-01 2024-06-30 13481836 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 13481836 bus:FullAccounts 2023-07-01 2024-06-30
COMPANY REGISTRATION NUMBER: 13481836
Askinyucelsin Limited
Filleted Unaudited Financial Statements
For the period ended
30 June 2024
Askinyucelsin Limited
Statement of Financial Position
30 June 2024
2024
2023
Note
£
£
Current assets
Cash at bank and in hand
2,037
7,067
Creditors: amounts falling due within one year
5
2,078
1,313
-------
-------
Net current (liabilities)/assets
( 41)
5,754
----
-------
Total assets less current liabilities
( 41)
5,754
----
-------
Capital and reserves
Called up share capital
100
100
Profit and loss account
( 141)
5,654
----
-------
Shareholder (deficit)/funds
( 41)
5,754
----
-------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 12 March 2025 , and are signed on behalf of the board by:
A Yucelsin
Director
Company registration number: 13481836
Askinyucelsin Limited
Notes to the Financial Statements
Year ended 30 June 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Hyde House, The Hyde, Edgware Road, London, NW9 6LA.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services rendered.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2023: 2 ).
5. Creditors: amounts falling due within one year
2024
2023
£
£
Other creditors
2,078
1,313
-------
-------
6. Director's advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2024
Balance brought forward
Advances/ (credits) to the director
Balance outstanding
£
£
£
A Yucelsin
( 1,313)
( 765)
( 2,078)
-------
----
-------
2023
Balance brought forward
Advances/ (credits) to the director
Balance outstanding
£
£
£
A Yucelsin
( 2,162)
849
( 1,313)
-------
----
-------